IPOs, crypto and deregulation: The SEC prepares for a shift in 2026
On December 2, 2025, SEC chairman Paul Atkins rang the opening bell at the NYSE and delivered a keynote address titled...
Regulatory & compliance archive
The new age of US bank deregulation: what it means for GRC professionals
The US is entering a new phase of financial deregulation, marked most visibly by the November 2025 decision by the Federal Deposit...
SEC’s 2026 exam priorities: data privacy takes center stage as crypto is dropped
On November 17, the SEC’s Division of Examinations released its 2026 examination priorities – a document that, as always, serves...
The week in GRC: The SEC reviews rules for ‘big four’ auditors as Starbucks faces a shareholder lawsuit
– The SEC is weighing changes to conflict of interest rules that restrict which companies the ‘big four’ accounting firms – KPMG...
SEC steps back from no-action reviews, leaving proxy season on unstable ground
The SEC has changed its rules around how companies seek permission to exclude certain shareholder proposals from proxies, in a...
The week in GRC: White House weighs up shareholder voting executive order as FTC launches probe into ISS and Glass Lewis
– US officials are reviewing an executive order that could reshape shareholder voting power by imposing curbs on major proxy...
The hidden backbone: Why entity management is key to strong corporate governance
Entity management remains the often overlooked yet crucial foundation supporting effective governance. Operating behind the scenes...
The cost of a crypto promise: Seoul court orders Wemade to deliver $7mn in tokens
When does a promise become a liability? For South Korea’s Wemade, the answer was clear: the moment it told employees they would...
The week in GRC: Elon Musk’s X reaches settlement with former Twitter execs as Atkins readies ‘innovation exemption’ crypto law
— SEC chair Paul Atkins is preparing to codify an ‘innovation exemption’, a regulatory carve-out designed to allow crypto and...
When politics enters the lab: What Trump’s Tylenol autism claim means for legal leaders in medicine
On September 22, President Donald Trump and HHS secretary Robert Kennedy Jr publicly claimed a link between prenatal use of...
